Wendy La, PharmD

home / authors / wendy-la-pharmd

Articles

Clinical Overview: Anti-CD38 Monoclonal Antibodies for Relapsed/Refractory Multiple Myeloma

Clinical Overview: Anti-CD38 Monoclonal Antibodies for Relapsed/Refractory Multiple Myeloma

February 7th 2023

Isatuximab and daratumumab offer promising treatment options for previously treated multiple myeloma.

Read More

Oncology Overview: Fam-trastuzumab Deruxtecan-nxki (Enhertu) for HER2-Positive Breast Cancer, Gastric Adenocarcinoma

Oncology Overview: Fam-trastuzumab Deruxtecan-nxki (Enhertu) for HER2-Positive Breast Cancer, Gastric Adenocarcinoma

July 13th 2022

The FDA has approved fam-trastuzumab deruxtecan-nxki (Enhertu) for previously treated HER2-positive breast cancer and gastric or gastroesophageal junction adenocarcinoma.

Read More

Clinical Overview: Ciprofloxacin/Dexamethasone for Acute Otitis Media, Acute Otitis Externa

Clinical Overview: Ciprofloxacin/Dexamethasone for Acute Otitis Media, Acute Otitis Externa

June 9th 2022

Ciprodex is approved for the treatment of ear infections, acute otitis media, and acute otitis externa.

Read More

© 2023 MJH Life Sciences

All rights reserved.